Upcoming FDA APPROVALS : March April 2026 . : r biotech_stocks Public Meeting: FDA Rare Disease Day 2026 02 23 2026 FDA Anticipated FDA Approvals for the First Quarter of 2026 Guideline Central A federal review is underway that could reclassify 14 peptides into FDA Category 1. This change that may influence how peptide therapies are accessed in the U.S. Here's what experts are March Roundup of FDA Approvals in Oncology: 4 Decisions to Know OncLive